Detalhe da pesquisa
1.
Comprehensive genomic profiles of small cell lung cancer.
Nature
; 524(7563): 47-53, 2015 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26168399
2.
Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer.
Mod Pathol
; 27(2): 214-21, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23887299
3.
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
Mod Pathol
; 25(11): 1473-80, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22684217
4.
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors.
Clin Cancer Res
; 22(19): 4837-4847, 2016 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27252416
5.
PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies.
Oncotarget
; 6(2): 1315-26, 2015 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25473901
6.
MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung.
Clin Cancer Res
; 21(4): 907-15, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25492085
7.
Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients.
J Thorac Oncol
; 10(7): 1049-57, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26102443
8.
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.
Nat Med
; 20(9): 1027-34, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25173427
9.
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.
Cancer Discov
; 4(2): 246-57, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24302556
10.
CD74-NRG1 fusions in lung adenocarcinoma.
Cancer Discov
; 4(4): 415-22, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24469108
11.
Activated RET and ROS: two new driver mutations in lung adenocarcinoma.
Transl Lung Cancer Res
; 2(2): 112-21, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25806222
12.
Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient.
J Thorac Oncol
; 10(6): e40-3, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26001148